Variant within the promoter region of the CHRNA3 gene associated with FTN dependence is not related to self-reported willingness to quit smoking.

Détails

Ressource 1Demande d'une copie Sous embargo indéterminé.
Accès restreint UNIL
Etat: Public
Version: de l'auteur⸱e
ID Serval
serval:BIB_2DFB9200F3C3
Type
Article: article d'un périodique ou d'un magazine.
Collection
Publications
Institution
Titre
Variant within the promoter region of the CHRNA3 gene associated with FTN dependence is not related to self-reported willingness to quit smoking.
Périodique
Nicotine and Tobacco Research
Auteur⸱e⸱s
Marques-Vidal P., Kutalik Z., Paccaud F., Bergmann S., Waeber G., Vollenweider P., Cornuz J.
ISSN
1469-994X (Electronic)
ISSN-L
1462-2203
Statut éditorial
Publié
Date de publication
2011
Peer-reviewed
Oui
Volume
13
Numéro
9
Pages
833-839
Langue
anglais
Notes
Publication types: Journal Article ; Research Support, Non-U.S. Gov't
Publication Status: ppublish
Résumé
INTRODUCTION: Common variation in the CHRNA5-CHRNA3-CHRNB4 gene region is robustly associated with smoking quantity. Conversely, the association between one of the most significant single nucleotide polymorphisms (SNPs; rs1051730 within the CHRNA3 gene) with perceived difficulty or willingness to quit smoking among current smokers is unknown.
METHODS: Cross-sectional study including current smokers, 502 women, and 552 men. Heaviness of smoking index (HSI), difficulty, attempting, and intention to quit smoking were assessed by questionnaire.
RESULTS: The rs1051730 SNP was associated with increased HSI (age, gender, and education-adjusted mean ± SE: 2.6 ± 0.1, 2.2 ± 0.1, and 2.0 ± 0.1 for AA, AG, and GG genotypes, respectively, p < .01). Multivariate logistic regression adjusting for gender, age, education, leisure-time physical activity, and personal history of cardiovascular or lung disease showed rs1051730 to be associated with higher smoking dependence (odds ratio [OR] and 95% CI for each additional A-allele: 1.38 [1.11-1.72] for smoking more than 20 cigarette equivalents/day; 1.31 [1.00-1.71] for an HSI ≥5 and 1.32 [1.05-1.65] for smoking 5 min after waking up) and borderline associated with difficulty to quit (OR = 1.29 [0.98-1.70]), but this relationship was no longer significant after adjusting for nicotine dependence. Also, no relationship was found with willingness (OR = 1.03 [0.85-1.26]), attempt (OR = 1.00 [0.83-1.20]), or preparation (OR = 0.95 [0.38-2.38]) to quit. Similar findings were obtained for other SNPs, but their effect on nicotine dependence was no longer significant after adjusting for rs1051730. Conclusions: These data confirm the effect of rs1051730 on nicotine dependence but failed to find any relationship with difficulty, willingness, and motivation to quit.
Mots-clé
Adult, Chromosomes, Human, Pair 15, Cross-Sectional Studies, Female, Genetic Predisposition to Disease, Humans, Male, Middle Aged, Motivation/genetics, Polymorphism, Single Nucleotide, Promoter Regions, Genetic, Questionnaires, Receptors, Nicotinic/genetics, Smoking/genetics, Smoking Cessation/psychology, Switzerland, Tobacco Use Disorder/genetics
Pubmed
Web of science
Création de la notice
04/05/2011 10:39
Dernière modification de la notice
20/08/2019 14:12
Données d'usage